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Abstract. 
 
Cell–matrix and cell–cell adhesion are recog-
nized physiological determinants of cell growth and 
survival. In epithelial and endothelial cell systems, on-
cogenic transformation has in several cases been shown 
to confer resistance to apoptosis upon depriving cells of 
substrate adhesion. We examined the effects of onco-
genic transformation in adherent versus adhesion-
deprived primary embryonic fibroblasts. Whereas un-
transformed early passage fibroblasts undergo cell 
cycle arrest, their Myc/Ras- or E1A/Ras-transformed 
counterparts rapidly enter apoptosis when placed into 
suspension. This phenomenon also occurs upon incuba-
tion with a soluble, RGD-containing integrin ligand 
and is blocked by a peptide antagonist to ICE family 
proteases or by aggregation of cells plated at high den-
sity. Loss of wild-type p53 modulates the kinetics but 
does not abrogate this death pathway. Transformation 
with activated Src rather than Ras rendered fibroblasts 
selectively resistant to adhesion-dependent apoptosis, 
an effect likely related to Src’s role in integrin signaling, 
while simultaneously sensitizing the cells to radiation-
induced apoptosis. Thus cell adhesion events regulate 
transformation-selective apoptosis in fibroblasts and 
provide potentially important targets for understanding 
and interfering with tumor cell viability.
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1. 
 
Abbreviations used in this paper
 
: ECM, extracellular matrix; FAK, focal
adhesion kinase; HUVEC, human umbilical vein endothelial cells; ICE,
interleukin-1
 
b
 
 converting enzyme; MEC, mammary epithelial cells; MEF,
mouse embryo fibroblasts; PARP, polyADP ribose polymerase; REF, rat
embryo fibroblasts; polyHEMA, polyhydroxyethylmethacrylate.
 
A
 
dhesion 
 
to the extracellular matrix (ECM)
 
1
 
 is a pro-
cess largely mediated by the integrin family of cell
surface receptors, which modulates a number of
pivotal cellular decisions ranging from embryonic devel-
opment and differentiation to tumor cell growth and me-
tastasis (Yamada and Miyamoto, 1995; Ruoslahti, 1996).
In addition to inducing tissue-specific gene expression, ad-
hesion of cells to the ECM has recently been shown to
serve as a survival mechanism in several anchorage-depen-
dent cell types. Primary cells of epithelial and endothelial
origin rapidly undergo apoptosis when denied proper sub-
strate adhesion in a process called anoikis (Frisch and
Francis, 1994; Ruoslahti and Reed, 1994). Human umbili-
cal vein endothelial cells (HUVEC) plated on agarose or
MDCK cells incubated in saturating amounts of either sol-
uble vitronectin or synthetic RGD-containing peptides are
prevented from adhering and rapidly undergo anoikis
(Meredith et al., 1993; Frisch and Francis, 1994). These
studies are consistent with others showing that ECM deg-
radation during normal development results in programmed
cell death of matrix-dependent cells (Re et al., 1994). Dur-
ing cavitation of the vertebrate embryo, inner endodermal
cells that do not contact the basement membrane are trig-
gered into apoptosis, while those retaining direct contact
are rescued (Coucouvanis and Martin, 1995).
The mechanism by which integrin-mediated adhesion
suppresses anoikis in these cell types, however, remains
unclear. Focal adhesion kinase (FAK), which is known to
bind and mediate integrin-dependent signals (Schaller et
al., 1992), has been shown to be required for the survival
of both primary (Hungerford et al., 1996) as well as tumor
cells (Xu et al., 1996) in the process of adhesion. Up-regu-
lation of Bcl-2 expression via the 
 
a
 
5
 
b
 
1 integrin in CHO
cells attached to fibronectin has been suggested as a po-
tential mechanism for the ECM’s ability to prevent apop-
tosis (Zhang et al., 1995). Activation of the Jun-NH
 
2
 
-ter-
minal kinase (JNK) in adhesion-deprived MDCK cells was
also recently suggested as a downstream signaling event
during anoikis (Frisch et al., 1996
 
a
 
). The p53 tumor sup-
pressor gene has also been suggested to modulate anoikis
of fibroblasts in an experimental metastasis system, in which
p53 loss was associated with enhanced survival of trans-
formed fibroblasts in suspension (Nikiforov et al., 1996).
Finally, inhibition of apoptosis by oncogenic transforma-
tion has been suggested as a mechanism for achieving an-
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chorage-independent growth potential of epithelial and
endothelial cells that have lost substrate attachment (Ruo-
slahti and Reed, 1994).
Apoptosis, now recognized as a major mode of action of
chemotherapy and radiotherapy, is a process whereby in-
dividual cells are triggered to self destroy in a manner that
will neither harm neighboring cells nor induce an inflam-
matory response (Martin, 1993; Williams and Smith, 1993;
Fisher, 1994). During the normal development of most if
not all multicellular organisms, apoptosis is an efficient ho-
meostatic mechanism whereby unwanted cells are elimi-
nated (Raff, 1992). The interleukin-1
 
b
 
 converting enzyme
(ICE) family of cysteine proteases, conserved from nema-
todes to mammals, has been implicated in mediating down-
stream events of apoptosis in a variety of systems (Martin
and Green, 1995; Nicholson et al., 1995; Tewari et al.,
1995; Chinnaiyan and Dixit, 1996). A number of specific
substrates for ICE family proteases have been described,
such as polyADP ribose polymerase (PARP), which is rap-
idly degraded within hours after ionizing radiation and
other apoptotic stimuli (Lazebnik et al., 1994). Tumor cells
harboring genetic mutations that block apoptosis may gain
a growth advantage under various stressful growth condi-
tions (Lowe et al., 1994; Graeber et al., 1996).
While sharing certain anchorage-dependent growth prop-
erties with the stationary cells that make up epithelial and
endothelial layers, fibroblasts are motile and do not exten-
sively adhere to one another (Stroker, 1968; Ben-Ze’ev et
al., 1980). Although these three cell types require matrix
adhesion and spreading to proliferate, nonadherent pri-
mary fibroblasts differ in that they arrest in the G
 
0
 
/G
 
1
 
phase of the cell cycle when deprived of adhesion and re-
duce their rate of macromolecular synthesis instead of un-
dergoing rapid apoptosis (Otsuka and Moscovitz, 1975;
Campisi and Medrano, 1983). The mechanisms that under-
lie this basic difference are not well understood. While on-
cogenic transformation has been suggested to rescue non-
adherent epithelial and endothelial cells from apoptosis,
its effect on nonadherent fibroblasts is less well under-
stood. A recent study by Nikiforov et al. (1996) reports
that transformation with E1A and ras oncogenes sensitizes
cells to p53-dependent anoikis. Anchorage-independent
growth of fibroblasts is a well established characteristic of
oncogenic transformation and is routinely assessed by
growth in a semi-solid medium. However such conditions
may not mimick true substrate detachment, thereby ob-
scuring a potential role for matrix adhesion in regulating
survival.
In this study we show that transformed fibroblasts are
triggered into apoptosis as a result of detachment from the
ECM, in contrast with primary fibroblasts, which arrest in
G
 
0
 
/G
 
1
 
. Both Myc/Ras and E1A/Ras oncogene combina-
tions transfected into rat embryo fibroblasts (REF) trigger
apoptosis after substrate detachment, as determined by
cellular morphology, DNA fragmentation, PARP cleav-
age, and the ability of an ICE family peptide inhibitor to
block this effect. A role for integrin-mediated signal trans-
duction is suggested through the ability of an RGD-con-
taining peptide to similarly trigger apoptosis in these cells.
While p53 null-transformed mouse embryo fibroblasts
were also sensitive to the loss of adhesion, p53 wild-type
cells displayed more rapid kinetics of death, suggesting a
p53-modulated pathway. In striking contrast, REF trans-
formed with either E1A/Src or Myc/Src were profoundly
resistant to apoptosis triggered by the loss of ECM, sug-
gesting that Src can mimick ECM survival signals normally
found in adherent cells. In addition, cells grown at high
densities became resistant to this apoptosis through the
formation of cell–cell contacts, which could be selectively
inhibited by the calcium chelator EDTA. These observa-
tions suggest an important role for both cell–matrix and
cell–cell signaling pathways in regulating the survival of
transformed fibroblasts.
 
Materials and Methods
 
Cell Culture Media and Reagents
 
Early passage primary REF (P1-P5; Rat Embryo Fibroblasts; BioWhi-
taker, Walkersville, MD) were grown in minimal essential medium
(MEM; GIBCO BRL, Gaithersburg, MD), supplemented with 20% FBS
(GIBCO BRL). REF were transfected by calcium phosphate coprecipita-
tion or lipofectamine reagent (GIBCO BRL) with long terminal repeat-
driven human 
 
c-myc
 
 or 
 
E1A
 
 and activated 
 
ras
 
 to generate the Myc/Ras-
and E1A/Ras-REF lines, respectively, or plasmid pKVS (containing 
 
v-src
 
)
and 
 
E1A
 
, or pMKVS plasmid (containing both 
 
v-myc
 
 and 
 
v-src
 
, gift of B.
Mathey-Prevot, Dana Farber Cancer Institute, Boston, MA; D’Emilia et
al., 1991) to generate E1A/Src- and Myc/Src-REF lines. Transformed foci
were picked 10–12 d after transfections. pB-SK carrier plasmid was used
for control transfection. All REF lines were grown in MEM with 20%
FBS. The Myc/Rat1 cell line (gift of Andrew Wagner and Nissim Hay,
Ben May Institute, Chicago, IL) was maintained in 10% FCS containing
DME with G418 sulfate (Geneticin/GIBCO BRL) and Hygromycin B
(Sigma Chemical Co., St. Louis, MO) at final concentrations of 500 and
200 
 
m
 
g/ml, respectively.
The murine fibroblast line C8 (E1A/Ras transfected mouse embryo fi-
broblasts [MEF] p53
 
1
 
/
 
1
 
) and A8 (E1A/Ras transfected MEF p53
 
2
 
/
 
2
 
 [both
gifts of Scott Lowe, David Housman, and Tyler Jacks, MIT, Cambridge,
MA]) were grown in DME with 20% FBS. Cells were grown without anti-
biotics (unless otherwise noted) and maintained in a humidified atmo-
sphere at 37
 
8
 
C in 5% CO
 
2
 
 in media supplemented with 
 
l
 
-glutamine.
 
Suspension Dishes
 
100-mm tissue culture dishes (Falcon; Becton Dickinson Labware, Franklin
Lakes, NJ) were used to maintain all cell lines. Suspension dishes were made
by coating 100-mm tissue culture dishes with 2 ml of a 12% solution of polyhy-
droxyethylmethacrylate polymer (poly-HEMA; Aldrich Chemical Co., Mil-
waukee, WI) in 190 proof ethanol (Folkman and Moscona, 1978) and allowed
to evaporate at 37
 
8
 
C for 40–48 h. Plates were washed with PBS before use.
 
DAPI Staining
 
10
 
5
 
 REF and E1A/Ras-REF were plated on tissue culture plastic (TCP) or
polyHEMA-coated TCP 100-mm dishes for 24 h before harvesting by cen-
trifugation. Cells were diluted in PBS and cytospun onto glass slides for 5
min. Tissue culture cells were then fixed in a 3:1 solution of methanol/ace-
tic acid for 20 min. Slides, plates, or coverslips were subsequently incu-
bated in the dark in a 0.01 mg/ml aqueous solution of DAPI (Sigma
Chemical Co.) at room temperature for 15 min and destained in 100%
methanol for 3 h before fluorescence microscopy.
 
DNA Fragmentation Assay
 
Cells from either adherent or suspension cultures were pooled for DNA
fragmentation analysis (Wagner et al., 1994). 5 
 
3
 
 10
 
6
 
 cells were washed
once with PBS and subsequently trypsinized with trypsin-EDTA (Sigma
Chemical Co.). Cells were pelleted and resuspended in 1 ml lysis solution
(10 mM Tris, pH 8.0, 100 mM NaCl, 25 mM EDTA, pH 8.0, 0.5% SDS, 0.5
mg/ml proteinase K), incubated 
 
z
 
15 h at 37
 
8
 
C, phenol/chloroform ex-
tracted twice, ethanol precipitated, and resuspended in 10 mM Tris, 1 mM
EDTA buffer, pH 7.5 (TE). Samples were then RNase A treated for 1 h at
37
 
8
 
C (final concentration of 100 
 
m
 
g/ml in TE), phenol/chloroform ex-
tracted twice, ethanol precipitated, resuspended in TE, and resolved on a 
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1.5% TAE-agarose gel, stained with ethidium bromide, visualized, and
photographed under short-wave UV.
 
Flow Cytometry and Viability Assays
 
Cell cycle analysis of REF or E1A/Ras-REF was performed 24 h after
plating 10
 
5
 
 cells on either TCP or polyHEMA-coated TCP. Cells were pel-
leted, washed, resuspended into 1 ml PBS on ice, fixed by adding 1 ml of
ice-cold 80% ethanol dropwise while vortexing, and incubated for 30 min
on ice. After washing again with 1 ml PBS, 5 
 
m
 
l of propidium iodide solu-
tion (0.5 mg/ml in PBS with 50 U/mg RNase A) was added and the cells
subsequently incubated in the dark at 37
 
8
 
C for 30 min. Cells remained on
ice until flow cytometric analysis was performed at the Dana Farber Can-
cer Institute Cell Sorting Facility on a FACScan
 
®
 
 Flow Cytometer (Bec-
ton Dickinson Immunocytometry Systems, Bedford, MA). Typically,
10,000 cells were collected per sample and analyzed on LYSYS II and
CELLFIT software.
For quantitation of apoptotic cells by flow cytometry and terminal
deoxynucleotidyl transferase-mediated dUTP-Biotin Nick-end Labeling
(TUNEL; Gavrieli et al., 1992), 10
 
5
 
 cells were grown on normal TCP or
polyHEMA-coated dishes and harvested 24, 48, 72, and 96 h after plating.
Cells plated on both types of dishes were trypsinized and washed with
PBS before fixation in 1% paraformaldehyde, pH 7.4, for 10 min on ice.
Labeling of DNA strand breaks with terminal transferase was subse-
quently performed using the ApopTag Fluorescein kit (Oncor, Gaithers-
burg, MD). After incubation with anti–digoxigenin-fluorescein antibody,
cells were counterstained with a 5 
 
m
 
g/ml propidium iodide and 50 
 
m
 
g/ml
RNase A solution for 30 min in the dark. The green (FITC) and red (PI)
fluorescence intensities of cells were measured using a FACScan
 
®
 
 Flow
Cytometer (Becton Dickinson Immunocytometry Systems). Cells were
collected and data stored using CELLFIT software and analyzed using
LYSYS II software. High and low fluorescence regions were determined
using adherent control samples and subsequently used to gate experimen-
tal samples to assess the number of apoptotic cells. Percent apoptosis was
calculated by dividing the number of cells displaying high fluorescence
levels with the total number of collected cells.
Trypan blue exclusion was also used to assess viability. To score as non-
viable, cells were counted only if 50% the diameter of viable cells, thereby
excluding over representation of apoptotic bodies (though perhaps
slightly underestimating the full magnitude of cell death). Data are pre-
sented as means 
 
6
 
 SD from three to five independent experiments.
 
Inhibition of Apoptosis Using an ICE Peptide Inhibitor
 
10
 
5
 
 E1A/Ras-REF and primary REF were plated on polyHEMA-coated
TCP either in the presence or absence of 100 
 
m
 
M Z-FA-fmk control pep-
tide or 100 
 
m
 
M Z-VAD-fmk inhibitor peptide for 12 h. 5 mg of both pep-
tides (Enzyme Systems Products, Dublin, CA) were dissolved in cell cul-
ture grade DMSO (Sigma Chemical Co.) to yield 20 mM stock
concentrations, and diluted into growth medium at 100 
 
m
 
M final concen-
tration by adding 40 
 
m
 
l of stock to 8 ml of medium just before plating cells.
Cells plated on polyHEMA with and without DMSO alone or on TCP
were used as controls.
 
Inhibiting Cellular Attachment with RGD Peptide
 
5 
 
3
 
 10
 
6
 
 A8 (p53
 
2
 
/
 
2
 
) cells were plated onto normal tissue culture plastic in
the presence of 1.5 mg/ml of either Gly-D-Arg-Gly-Asp-Ser-Pro (GdRGDSP)
synthetic peptide (fibronectin/vitronectin ligand competitor; GIBCO BRL)
or Gly-Arg-Gly-Glu-Ser-Pro (GRGESP) control peptide (GIBCO BRL).
Peptide stocks were prepared in DME supplemented with 10% FCS with
100 U/ml penicillin and 100 
 
m
 
g/ml streptomycin and were added at the
time of plating. DNA fragmentation analysis was carried out after 12 h in-
cubation with either peptide.
 
In Vitro Cleavage of PARP by Cell Extracts
 
Cytosolic extracts were isolated from E1A/Ras-transformed REF 6 h after
plating onto polyHEMA or TCP and prepared essentially as previously
described (Nicholson et al., 1995). All adherent and floating cells from
each culture were pooled and 2 
 
3
 
 10
 
6
 
 cells lysed in 50 
 
m
 
l 10 mM Hepes/
KOH (pH 7.4), 2 mM EDTA, 0.1% CHAPS, 5 mM dithiothreitol, 1 mM
phenylmethylsulfonylfluoride, 10 
 
m
 
g/ml pepstatin A, 20 
 
m
 
g/ml leupeptin,
10 
 
m
 
g/ml aprotinin on ice for 10 min, followed by centrifugation at 10,000 
 
g.
 
An NH
 
2
 
-terminal PARP fragment that spans the specific cysteine pro-
tease cleavage site was expressed as a His-tagged chimera (plasmid gener-
ously provided by Dr. John Collier, Harvard Medical School, Boston,
MA), and the protein was purified by nickel chelate chromatography in
6 M guanidine HCl per manufacturers recommendations (Qiagen, Chats-
worth, CA). 800 ng of recombinant PARP was added to 40 
 
m
 
l of 10,000 
 
g
 
supernatant and incubated at 37
 
8
 
C for 1 h. Samples were resolved on
SDS-PAGE minigels, transferred to nitrocellulose for 40 min at 50 V,
blocked overnight at 4
 
8
 
C in 150 mM NaCl, 50 mM Tris (pH 8.0), and 5%
powdered milk, washed with Tris-buffered saline and Tween 20 (TBST),
incubated with C2-10 
 
a
 
PARP monoclonal antibody (gift of Guy Poirier
Université Lavat, Quebec, Canada) 1:10,000 in TBST for 2 h at room tem-
perature, washed with TBST, and finally incubated with Peroxidase-con-
jugated goat anti–mouse antibody 1:10,000 in TBST (Cappel Laborato-
ries, Cochranville, PA). ECL (Renaissance; Dupont NEN, Boston, MA)
was then performed for 1 min at room temperature according to the man-
ufacturer’s recommendations.
 
Results
 
Loss of ECM Adhesion Triggers
Transformation-specific Apoptosis in Fibroblasts
 
We have studied the response of primary untransformed
and transformed REF to the loss of matrix adhesion. Myc/
Ras- or E1A/Ras-transformed lines were generated from
parental REF cells by lipofection and plated on tissue cul-
ture plastic (TCP) or polyHEMA-coated TCP. Agarose
gel electrophoresis of genomic DNA isolated from Myc/
Ras-REF (Fig. 1 
 
A
 
, lane 
 
7
 
) but not primary REF (lane 
 
4
 
)
plated onto polyHEMA displayed oligonucleosomal lad-
dering of 
 
z
 
180–200 bp in length, a characteristic feature of
apoptosis. This behavior was also observed in Myc-trans-
formed Rat1 fibroblasts (Fig. 1 
 
B
 
), an oncogene/apoptosis
system that has been extensively studied for apoptosis
upon growth factor withdrawal (Askew et al., 1991; Evan
et al., 1991; Wagner et al., 1994). While previous studies
have demonstrated polyHEMA’s ability to prevent matrix
deposition on wettable tissue culture polystyrene and to
be nontoxic to cells (Folkman and Moscona, 1978; Ben-
Ze’ev et al., 1980; O’Neill et al., 1986; Schwartz et al., 1989;
Frisch and Francis, 1994; Re et al., 1994), we found that
bacterial Petri dishes also prevented cellular adhesion,
thereby controlling for the effect of this polymer coating.
Myc/Ras-REF on bacterial Petri dishes behaved similarly
to those on polyHEMA-coated TCP and displayed the
same DNA ladder pattern after 24 h (Fig. 1 
 
A
 
, lanes 
 
6
 
 and
 
7
 
), suggesting that the loss of anchorage (and not the poly-
HEMA treatment itself) was responsible for apoptosis.
Nuclear staining of cells with DAPI revealed shrinkage
and nuclear condensation, characteristic of apoptotic cell
death (Fig. 1 
 
C
 
). In contrast, untransformed, primary REF
lacked these morphological changes. As early as 12 h after
plating onto polyHEMA, viability of E1A/Ras- and Myc/
Ras-REF was greatly reduced as compared to the parental
primary REF (Fig. 1 
 
D
 
) using trypan blue exclusion. This
effect was reproducible in multiple, independently derived
foci for each oncogene combination.
A predominant sub-G
 
1
 
 population characteristic of apop-
tosis was also observed in nonadherent, transformed cells
by propidium iodide staining and flow cytometric analysis
(Fig. 2 
 
D
 
). In agreement with earlier studies (Campisi and
Medrano, 1983), primary REF were found to arrest when
grown in suspension (Fig. 2 
 
B
 
). Cell cycle quantitation was
derived from histograms shown in Fig. 2 (see Materials
and Methods) and revealed both a 13% increase in the G
 
1 
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population (from 56 to 69%) and a 13% decrease in S
phase (from 29 to 16%); G
 
2
 
/M remained constant at 15%.
Suspended REF remained 
 
.
 
90% viable over at least 72 h
(data not shown). Controls on regular TCP for primary
and transformed REF showed DNA distribution of log-
phase cells (Fig. 2, 
 
A
 
 and 
 
C
 
).
 
Cysteine Protease Activity Accompanies Apoptosis 
Triggered by Loss of ECM Adhesion
 
We asked whether ICE-family cysteine protease activity is
required for apoptosis to occur in transformed fibroblasts
denied ECM (Fig. 3). To test this, we incubated 10
 
5
 
 E1A/
Ras-REF cells on polyHEMA with either the ICE pro-
Figure 1. Rat embryo fibroblasts transformed with Myc/Ras or E1A/Ras are triggered into apoptosis when deprived of substrate adhe-
sion. (A) Oligonucleosomal genomic DNA fragmentation. Early passage primary REF and Myc/Ras-REF were plated on either tissue
culture plastic (lanes 2 and 5), bacterial petri (3 and 6), or polyHEMA-coated TCP dishes (4 and 7), and genomic DNA was isolated
from 5 3 106 cells as described in the Materials and Methods. (B) Myc/Rat1 cells were plated on TCP (T) or polyHEMA (H) as above,
and genomic DNA was isolated from 5 3 106 cells as described in Materials and Methods. (C) E1A/Ras-REF and parental REF were
plated on TCP or polyHEMA-coated TCP for 12 h before nuclear staining with DAPI as described in Materials and Methods. (D) REF
clones transformed with oncogenes Myc/Ras or E1A/Ras or early passage primary REF were plated at 105 cells/100-mm dish on TCP
(open bars) or polyHEMA-coated TCP (closed bars). Viability was measured 12 h after plating by calculating the ratio of trypan blue-
positive cells to live cells (see Materials and Methods). 
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tease inhibitor Z-VAD-fmk, or as control, the cathepsin B
protease inhibitor Z-FA-fmk both at 100 
 
m
 
M final concen-
tration in medium as previously described (Pronk et al.,
1996). Whereas 
 
.
 
80% of the suspended transformed cells
died by 12 h in the absence of peptide, we observed a
marked decrease in death (down to 
 
z
 
15%) for cells incu-
bated with Z-VAD-fmk (Fig. 3 
 
A
 
). The viability of cells in
the presence of Z-FA-fmk remained unchanged at 
 
z85%.
Furthermore, addition of recombinant PARP to S-10 ex-
tract of suspension E1A/Ras-REF (see Materials and
Methods) revealed the specific cleavage characteristic of
ICE family/CPP32 activation in apoptotic cells (Fig. 3 B).
Apoptosis Triggered by the Loss of Adhesion Can Occur 
in the Absence of p53
Oncogene-driven apoptosis induced by a variety of trig-
gers is commonly modulated by wild-type p53 protein
(Yonish-Rouach et al., 1991; Debbas and White, 1993).
E1A/Ras-transformed p53 wild-type– or null MEF have
served as a model of genetically related cell lines to exam-
ine the capacity of p53 to regulate apoptosis after treat-
ment with chemotherapeutic agents, ionizing radiation, or
hypoxia (Lowe et al., 1993a, 1994; Graeber et al., 1996).
We investigated whether suspension-induced apoptosis
was modulated by the presence or absence of p53. Quanti-
tation of cell death after 72 h on polyHEMA showed ex-
tensive death of p53 wild-type–transformed fibroblasts and
significant, but reproducibly lower levels of death in the
p53 null cells (Fig. 4 A). Oligonucleosomal DNA degrada-
tion was observed for both C8 and A8 lines on poly-
HEMA, confirming that the loss of viability observed by
trypan blue is due to apoptosis (Fig. 4 B). Using DNA
fragmentation TUNEL staining and flow cytometry, the
kinetics of apoptotic death was delayed by z2 d in E1A/
Ras-transformed p532/2 cells as compared to p531/1 (data
not shown). Thus this death pathway may be potentiated
by the presence of p53 but is not abrogated by loss of p53.
Figure 2. Flow cytometric analysis of REF and E1A/Ras-REF
plated on TCP or polyHEMA-coated TCP dishes. 24 h after plat-
ing, cells were washed, fixed, and stained with propidium iodide
as described in Materials and Methods. DNA content was plotted
on a logarithmic scale to expand the sub-G1 apoptotic fraction.
Cell cycle fractions are given in the text. 10,000 events were
counted in all, but the E1A/Ras-REF in suspension represented
fewer events, as indicated by the y axis amplitude due to cell loss
by apoptosis. (D, Note that fewer events were counted in the apop-
totic versus nonapoptotic samples as indicated by the abscissa.)
Figure 3. (A) Apoptosis triggered by the loss of ECM adhesion is
blocked by inhibition of an ICE-like protease. 105 E1A/Ras-REF
per 100-mm dish were plated on TCP or on polyHEMA-coated
TCP in the presence or absence of 100 mM Z-FA-fmk control
peptide or 100 mM Z-VAD-fmk inhibitor peptide (the same
amount of DMSO carrier used to dissolve the peptides was added
to cells as a control). Viability was determined by trypan blue
staining after 12 h. Bars represent the average of three experi-
ments (6SD). (B) Loss of ECM adhesion in transformed fibro-
blasts leads to activation of the Yama/CPP32 cysteine protease
and results in PARP cleavage.The Journal of Cell Biology, Volume 138, 1997 906
Inhibition of Integrin Signaling Triggers Apoptosis in 
Transformed Fibroblasts
We investigated the role of integrins in mediating the
ECM’s ability to rescue cells from apoptosis. An RGD-
containing peptide that competes for the binding of the fi-
bronectin and vitronectin receptors to their respective
ECM substrates was used to test this hypothesis. E1A/
Ras-MEF (p532/2) were plated onto TCP in the presence
of 1.5 mg/ml of either RGD- or RGE-soluble peptides (in
culture medium). A dose titration of RGD peptide added
at the time of plating revealed this concentration to com-
pletely block adhesion to TCP (data not shown). Genomic
DNA fragmentation analysis performed 12 h after plating
cells demonstrated an oligonucleosomal DNA ladder for
RGD-treated cells, whereas the same cells incubated with
control RGE peptide were morphologically healthy and
displayed minimal DNA degradation (Fig. 5).
v-Src Transformation Sensitizes to Radiation but 
Blocks Adhesion-dependent Apoptosis
Recognizing a potential role for integrin-mediated signal
transduction in triggering apoptosis of transformed cells
denied ECM contact, we sought to examine this cascade
further downstream. Clustering of ECM-bound integrins
and formation of focal contacts results in the localization
of FAK to these sites and subsequent recruitment and ac-
tivation of Src tyrosine kinase (Guan and Shaloway, 1992;
Kornberg et al., 1992; Schaller et al., 1992; Schlaepfer et
al., 1994). Transfection of Src has previously been shown
to confer anchorage-independent growth to epithelial, en-
dothelial, and fibroblast cells (MacCauley and Pawson,
1988; Frisch and Francis, 1994; Re et al., 1994). We there-
fore asked whether Src-transformed fibroblasts display the
same sensitivity to apoptosis by traditional triggers, such
as ionizing radiation, as well as loss of substrate adhesion.
Multiple independent E1A/Src- and Myc/Src-REF–trans-
formed clones were generated from primary REF cells
and tested for radiation sensitivity and survival in suspen-
sion (Fig. 6). Src transformation profoundly sensitized
cells to g radiation, an oncogene sensitizing effect similar
to that seen in E1A/Ras- and Myc/Ras-transformed rat fi-
broblasts (Fig. 6) and E1A/Ras-transformed mouse fibro-
blasts, relative to primary fibroblast cells (Lowe et al.,
1994). In contrast, however, all Src-transformed cell lines
were resistant to apoptosis triggered by loss of adhesion.
In fact a number of these cell clones were able to prolifer-
ate (and be passaged) in suspension. Thus Ras-dependent
Figure 4. E1A/Ras-trans-
formed MEF lacking p53
are sensitive to apoptosis
triggered by the loss of sub-
strate adhesion. (A) Viability
of E1A/Ras-transformed
MEF1/1 and MEF2/2 plate
on polyHEMA-coated TCP
or regular TCP dishes after
72 h (determined as de-
scribed in Fig. 1 A). (B)
Oligonucleosomal genomic
DNA fragmentation. E1A/
Ras-transformed MEF1/1
and MEF2/2 were plated on
either TCP (lanes 2 and 4)
or polyHEMA-coated TCP
dishes (3 and 5) for 48 h. Ge-
nomic DNA was isolated
from 5 3 106 cells as previ-
ously described.
Figure 5. Inhibition of fibronectin/
vitronectin-mediated adhesion of
p532/2 transformed fibroblasts trig-
gers apoptosis. E1A/Ras-MEF
(p532/2) were plated onto regular
TCP dishes in the presence of satu-
rating amounts (1.5 mg/ml) of ei-
ther GRGDSP (lane 3) or
GRGESP control peptide (lane 2).
12 h after plating, cells were har-
vested and genomic DNA was iso-
lated as previously described.McGill et al. Suspension-induced Apoptosis in Transformed Fibroblasts 907
transformation differed profoundly from Src in sensitizing
fibroblasts to adhesion-dependent apoptosis.
Cell–Cell Aggregation Can Rescue Ras-transformed 
Fibroblasts from Apoptosis in Suspension
In comparing suspension growth characteristics of primary
versus Ras-transformed REF cells, we observed a correla-
tion between plating density, cellular aggregation, and cell
survival. While primary REF plated at high density on
polyHEMA remain mostly single cells after plating (Fig. 7
A), Myc/Ras-REF (or E1A/Ras-REF, data not shown) are
largely aggregated and predominantly viable. We there-
fore considered the possibility that cell–cell contacts could
be protective in the absence of ECM adhesion. E1A/Ras-
REF were plated at varying cell densities both on TCP-
and polyHEMA-coated, 100-mm dishes in an attempt to
vary the propensity for cell–cell aggregation and uncouple
this phenomenon from that of cell–matrix adhesion. At
densities of 5 3 104 or 105 per plate, cells remained single
and unaggregated (data not shown) and displayed maxi-
mum levels of death, whereas at densities of 106 or 5 3 106
per plate, cellular aggregation was observed together with
markedly reduced death (Fig. 7 B, closed circles). The non-
linear shape of the viability curve suggested the presence
of a critical cell density to achieve rescue from apoptosis.
The same E1A/Ras-REF plated on regular TCP showed
insignificant levels of cell death at all densities (Fig. 7 B,
open squares).
The precise molecular determinants of this cell–cell ag-
gregation and rescue are unknown. However, since nu-
merous cell adhesion molecules require Ca21, we tested
the effect of the calcium chelator EDTA on the aggrega-
tion and viability of E1A/Ras-REF plated at high density
on polyHEMA. Parental REF cells and adherent trans-
formed cells served as controls to assess nonspecific toxic-
ity of EDTA. At a dose of 1 mM EDTA added to the
usual growth media, untransformed REF displayed no sig-
nificant change in viability. Similarly, the viability and ad-
hesion properties of E1A/Ras-transformed REF on normal
TCP at densities of 105 or 106 was essentially unaffected by
EDTA. In contrast, 1 mM EDTA resulted in a z60% in-
crease in cell death of transformed cells plated at 106 cells/
100-mm dish, a density that typically favors cell–cell con-
tacts and rescues cells from apoptosis (Fig. 7, A and C). A
substantial decrease in the number and size of cell aggre-
gates was observed, although many dead cells also ap-
peared to remain in clusters (data not shown). While the
identity of the specific molecules affected by this low dose
EDTA is not yet known, it may be interesting that under
Figure 6. Src rescues transformed fibroblasts from apoptosis triggered by the loss of ECM adhesion. Three separately grown clones
were isolated from REF cultures transfected with either E1A and Src or Myc and Src (filled bars). 105 cells from each clone were plated
onto polyHEMA-coated TCP (HEMA), regular TCP dishes (TCP), or regular TCP dishes and irradiated after 24 h with 500 cGy ioniz-
ing radiation (5Gy XRT). Viability was determined by trypan blue 24 h after plating onto TCP or polyHEMA and 24 h after radiation
for XRT controls. Bars represent the average of three experiments (6SD).The Journal of Cell Biology, Volume 138, 1997 908
these conditions, minimal loss of matrix adhesion occurred
for the adherent controls, suggesting that integrin attach-
ment was spared despite its divalent cation requirements.
Thus, low dose EDTA produces a transformation-depen-
dent and suspension-specific restoration of apoptotic
death.
Discussion
Preventing ECM adhesion of fibroblasts transformed by
Myc and Ras or E1A and Ras leads to rapid cell death by
apoptosis. This phenomenon was observed in a number of
independently derived foci and displays the classical fea-
tures of apoptotic cell death (DNA fragmentation, mor-
phology, ICE-family cysteine protease activity). This re-
sponse contrasts with that of untransformed fibroblasts
that remain .95% viable and lack morphological or bio-
chemical evidence of apoptosis. In agreement with a num-
ber of previous studies examining fibroblast adhesion
(Stroker, 1968; Folkman and Moscona, 1978; Ben-Ze’ev et
al., 1980; Campisi and Medrano, 1983), cell cycle analysis
of primary rat fibroblasts revealed an increase in G0/G1-
arrested cells. Interestingly, recent analysis of primary
chick embryo fibroblasts has revealed a greater propensity
for anoikis, particularly in the absence of serum (Hunger-
ford et al., 1996). In transformed rat fibroblasts, a soluble
RGD-containing peptide that blocks attachment to fi-
bronectin and vitronectin (Pierschbacher and Ruoslahti,
1987) also triggered apoptosis, suggesting that integrin-
mediated events (e.g., direct signaling and/or regulation of
cell shape) can regulate transformation-specific death de-
cisions in fibroblasts. The effect of this peptide on cell ad-
hesion and viability suggests that integrin engagement
without clustering is insufficient to protect from apoptosis
and also implies that protection in these cells may be spe-
cifically mediated via either the a5b1 or avb1 receptors.
The a5b1 integrin has recently been shown to support the
survival of CHO cells on fibronectin in a manner that cor-
relates with increased levels of Bcl-2 mRNA and protein
(Zhang et al., 1995). Whether other combinations of in-
tegrin heterodimers also transmit protective signals is un-
certain, especially in light of studies suggesting that the re-
sponse to the loss of ECM adhesion may be cell-type
specific (i.e., growth arrest in primary fibroblasts versus
apoptosis in epithelial or endothelial cells).
The behavior of fibroblasts denied attachment appears
to differ from epithelial and endothelial cell suspension
systems in which primary cells appeared sensitive to apop-
tosis and oncogene transformation produced resistance
(see below). It is unclear why primary rodent fibroblasts
Figure 7. Cell–cell clustering rescues transformed fibroblasts in
the absence of cell–matrix contact. (A) Early passage, primary
REF or Myc/Ras-REF were plated onto TCP or polyHEMA-
coated TCP at high density (2 3 106 cells per 100-mm dish) and
photographed under phase contrast microscopy after 24 h. For
transformed cells in suspension, representative aggregates are
shown. (B) E1A/Ras-REF cells were plated on polyHEMA-
coated TCP or regular TCP 100-mm dishes at indicated cell den-
sities. Viability was determined by trypan blue staining 24 h after
plating. Bars represent the average of three experiments (6SD).
(C) 1 mM of the calcium chelator EDTA restores apoptosis of
E1A/Ras-transformed fibroblasts plated at high density (106),
while having no effect on adherent cells or REF under the same
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survive adhesion-free conditions, while epithelial and en-
dothelial cells do not, but this behavior may also underlie
the differing effects of transformation, particularly with
activated Ras, which sensitizes, rather than protects fibro-
blasts from adhesion-dependent apoptosis. Transforma-
tion of fibroblasts with either Myc or E1A has previously
been shown to sensitize them to apoptosis after growth
factor deprivation (Askew et al., 1991; Evan et al., 1991;
Debbas and White, 1993). In fact the behavior after depri-
vation of substrate attachment mimicks growth factor dep-
rivation. Of note, for Ras-transformed cells the sensitivity
to anoikis was greatest at low rather than high cell density,
arguing against the possibility that growth factor depriva-
tion itself was actually triggering death in these studies.
E1A/Ras transformation has been found to sensitize fibro-
blasts to apoptosis from ionizing radiation and a variety of
chemotherapeutic agents (Lowe et al., 1993a,b). Onco-
gene-sensitized apoptosis often appears to be mediated by
p53, whose loss renders transformed fibroblasts substan-
tially resistant to radiation and many chemotherapeutic
apoptosis triggers in vitro, in murine solid tumors (Lowe et
al., 1993b, 1994), and in human cancers where p53 status is
prognostically meaningful (Hollstein et al., 1991; Harris
and Hollstein, 1993; Fisher, 1994; Fung and Fisher, 1995;
Shimamura and Fisher, 1996). The same genotoxic treat-
ments that trigger p53-mediated apoptosis in transformed
fibroblasts typically induce cell-cycle arrest (without death)
in untransformed cells, a behavior observed here with loss
of substrate attachment as well.
Using genetically related E1A/Ras-transformed mouse
fibroblast lines differing in the presence or absence of p53,
we observed significant apoptosis in both the presence and
absence of p53, although the kinetics of this death was
slower in the latter case. This delay could provide a selec-
tive advantage to tumor cells lacking functional p53 and
manifest itself in altered propensity for tumor cell me-
tastasis. In fact, our observations support the recent report
of p53-modulated anoikis (Nikiforov et al., 1996), in which
p53 loss was associated with enhanced survival of trans-
formed fibroblasts in suspension. Importantly, however,
the p53 null transformed fibroblasts studied here did un-
dergo massive (albeit delayed) adhesion-dependent apop-
tosis, suggesting the possibility that drugs that interfere
with tumor cell-ECM signaling might hold therapeutic
promise in p53 deficient tumors. 
Our observations using Myc- (or E1A) plus Ras-trans-
formed fibroblasts confirm the notion that the ECM may
act as a cell survival factor and that the loss of ECM at-
tachment is cell-type specific. Studies examining anchor-
age-dependent apoptosis in epithelial or endothelial cells
have suggested that this phenomenon is likely to play a
role in cell positioning (Ruoslahti and Reed, 1994). Unlike
primary fibroblasts, untransformed epithelial and endo-
thelial cells undergo apoptosis rather than growth arrest
when placed in suspension (Meredith et al., 1993; Frisch
and Francis, 1994; Re et al., 1994; Ruoslahti and Reed,
1994; Boudreau et al., 1995). HUVEC plated on agarose-
coated tissue culture dishes and prevented from adhesion
rapidly die by apoptosis, while plating them on dishes
coated with the b1 integrin (but not HLA class I or
VCAM-1) rescues them (Meredith et al., 1993). Consistent
with these results are studies by Re et al. (1994) and Frisch
and Francis (1994) that show that blocking integrin recep-
tors of HUVEC or MDCK cells with either saturating
amounts of soluble vitronectin or soluble RGD peptide
prevents substrate attachment and leads to apoptosis.
Boudreau et al. (1995) demonstrate that, in vitro, attach-
ment of mammary epithelial cells (MEC) to a basement
membrane via the b1 integrin reduces ICE mRNA levels.
Their results also suggest that active ECM degradation
during normal mammary gland involution results in apop-
tosis of cells that depend on it. Ectopic expression of the
ECM-degrading metalloproteinase stromelysin-1 in MEC
leads to apoptosis, which is inhibited by the specific pro-
tease inhibitor GM6001. In addition, transgenic mice ex-
pressing stromelysin-1 under the control of a promoter ac-
tive during mid- to late pregnancy results in apoptosis of
MEC during this period (Boudreau et al., 1995). Unlike
stationary epithelial and endothelial cells that form tight
sheets as a result of intercellular junctions, one might ex-
pect that migratory cells of mesenchymal origin like pri-
mary fibroblasts would not possess the same apoptosis
program in response to the loss of ECM contact.
While Myc/Ras or E1A/Ras transformation of fibro-
blasts sensitizes them to apoptosis triggered by the loss of
ECM as well as to genotoxic stress, this response is not
paralleled in endothelial and epithelial cell types, where
oncogenic transformation has been found to confer resis-
tance to anchorage-dependent apoptosis (Frisch and Fran-
cis, 1994; Re et al., 1994; Rak et al., 1995). Endothelial cells
transformed with either SV40 large-T antigen or v-Ras and
grown on polyHEMA are less susceptible to apoptosis
than their untransformed counterparts (Re et al., 1994).
Immortalized intestinal epithelial cells IEC-18 condition-
ally expressing mutant c-H-Ras protein are rescued from
apoptosis induced by three-dimensional growth conditions
(Rak et al., 1995). In addition, in a reverse-transformation
model of the HT1080 human fibrosarcoma line (Frisch,
1991), E1A sensitized these cells to apoptosis upon loss of
anchorage (Frisch and Francis, 1994). HT1080 cells are
also triggered into apoptosis when incubated with the
laminin-mimetic peptide YIGSR (Kim et al., 1994), sug-
gesting that reverse transformation is not absolutely re-
quired to sensitize these cells to apoptosis in suspension.
One possible connection between Ras behavior in fibro-
blasts and its protection against anoikis in epithelial or en-
dothelial cells could relate to intercellular adhesion. Prior
studies (Jamal et al., 1994) have suggested that Ras activ-
ity may stimulate expression of CD44, a modulator of in-
tracellular adhesion. The propensity of Ras-transformed
cells to aggregate (shown here to correlate with rescue
from anoikis) may thereby confer survival via a specific
cell–cell adhesion pathway in both fibroblasts and epithe-
lial cell types.
Given Src’s involvement in integrin signaling, we hy-
pothesized that v-Src transformation might be protective
to fibroblasts grown in suspension. In striking contrast to
Ras-transformed REF, both Myc/Src-REF and E1A/Src-
REF were profoundly resistant to the modulation of apop-
tosis when plated onto polyHEMA-coated tissue culture
plates. However, the same Src-transformed cell lines were
simultaneously sensitized (relative to parental REF) to
ionizing radiation, a trigger of p53-modulated apoptosis
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ally disabled in these cells. These results agree with studies
showing that Src transformation protects MDCK cells and
HUVECs from anoikis (Frisch and Francis, 1994; Re et al.,
1994). Although a variety of mechanisms could potentially
account for this behavior, Src activation may mimick ECM
survival signals required by transformed cells (irrespective
of cell type) to survive in suspension, thereby conferring
anchorage-independent growth potential. Another point
raised by this observation is the possibility that Src-trans-
formed cells could display a different survival behavior
within animals, possibly relating to metastatic potential for
example.
Recent studies have shown that permanent membrane
localization of FAK in MDCK cells prevents apoptosis in
suspension, supporting the notion that activation of signal-
ing intermediates in this adhesion pathway (like Src) may
protect cells from anoikis (Frisch et al., 1996b). Moreover,
preventing integrin binding to FAK through competition
with microinjected synthetic peptides triggers rapid apop-
tosis in primary chick embryo fibroblasts grown in the ab-
sence of serum (Hungerford et al., 1996). The apoptosis
resistance we observed with primary REF may reflect in-
tegrin-independent activation of such signaling intermedi-
ates or alternatively distinct downstream nuclear events
that signal arrest versus apoptose. For the current studies,
we have attempted to uncouple growth factor influences
from anoikis by use of 20% serum in all experiments.
Given the specific role of Ras in growth factor signaling as
well as in the transformation-specific anoikis reported
here, these apoptotic pathways may share certain mecha-
nistic components that should be amenable to study in
these genetically related cells.
Whereas integrins may mediate cell–matrix signals to
prevent growth arrest or apoptosis, cell–cell adhesion via
integrin-dependent or independent mechanisms may also
generate signals that block apoptosis. Establishment and
maintenance of cell–cell contacts in epithelial and endo-
thelial cell types plays a central role in determining cellu-
lar polarity and ensuring correct tissue function (Birch-
meier et al., 1993; Birchmeier and Birchmeier, 1994). In
addition, studies have demonstrated that cell–cell contacts
can modulate a drug-induced cell death pathway (Koba-
yashi et al., 1993; Kerbel et al., 1995). Inhibition of inter-
cellular contact has been shown to trigger rapid apoptosis
in the colon carcinoma line LIM 1863, which normally
grows in aggregates termed “organoids” (Bates et al., 1994).
In this study, we observed a striking difference in the be-
havior of primary and transformed fibroblasts in suspen-
sion. Unlike primary REF which remain mostly as single
cells in suspension, E1A/Ras- and Myc/Ras-transformed
REF aggregate into clusters. In these aggregates, trans-
formed cells likely require specific signals generated from
cell–cell contacts to survive. The suspension-dependent ef-
fect of low dose EDTA on these cells further suggests that
cell–cell survival signals are mediated by a Ca21-requiring
molecule(s) like integrins and/or the cadherin family of in-
tercellular receptors (Grunwald, 1993; Takeichi, 1993;
Gumbiner, 1996). Other potential candidates include CD44,
a molecule associated with metastasis propensity (Günthert
et al., 1991) and shown to be overexpressed upon both Ras
and Src transformation (Hofmann et al., 1993; Jamal et al.,
1994). Interestingly, Src-transformed fibroblast lines showed
a much greater propensity to grow as single cells in sus-
pension (data not shown), consistent with the likelihood
that Src’s survival signal does not require cell–cell contact.
The observations reported here strongly suggest that
survival in suspension is not synonymous with “anchorage
independence,” a term traditionally employed to describe
colony formation in semi-solid medium. Growth in semi-
solid medium distinguishes transformed from untrans-
formed REF, and oncogene-transformed cells used in
these studies readily form colonies in soft agar (data not
shown) while undergoing rapid anoikis in suspension.
Moreover, the conferral of anoikis sensitivity in fibroblasts
upon oncogene transfection is a relatively stringent assay
of oncogene function given that it would produce a nega-
tive selection bias during the establishment of transformed
lines.
The in vivo relevance of cell–cell signaling in modulat-
ing apoptosis of tumor cells in suspension is implicit in
studies demonstrating the importance of intercellular junc-
tions during colon carcinogenesis. The identification of the
product of the adenomatous polyposis coli (APC) tumor
suppressor gene as a protein that binds to b-catenin (Ru-
binfeld et al., 1993) as well as its anti-apoptotic activity
(Morin et al., 1996) suggest that its tumor suppressive role
could be related to a role in cell–cell adhesion and sur-
vival. Further analysis of signaling events both from integ-
rin/Src and cell–cell adhesion receptors may reveal tumor-
specific survival pathways and potential drug targets in
malignancies such as sarcomas.
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